| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 82637-57-8 | (S)-2-[(S)-2-((S)-1-乙氧羰基-3-苯基丙基氨基)丙�；鵠-6,7-二甲氧基-1,2,3,4-四氫異喹啉-3-甲酸芐酯 | (S)-2-[(S)-2-((S)-1-Ethoxycarbonyl-3-phenylpropylamino)propionyl]-6,7-dimethoxy-1,2,3,4-tetrahyd; 2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid phenylmethyl ester |  | C34H40N2O7 | 詳情 | 供應(yīng)商 |
| 103775-10-6 | 莫西普利; 莫昔普利; 2-[2-[(1-乙氧基甲酰-3-苯基丙基)氨基]丙�；鵠-6,7-二甲氧基-3,4-二氫-1H-異喹啉-3-羧酸 | Moexipril; 2-[2-[(1-Ethoxycarbonyl-3-phenyl-propyl)amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid |  | C27H34N2O7 | 詳情 | 供應(yīng)商 |
| 127294-70-6 | 巴洛沙星; 1-環(huán)丙基-7-(3-甲氨基-1-哌啶基)-8-甲氧基-6-氟-1,4-二氫-4-氧代-3-喹啉羧酸 | Balofloxacin; 1-Cyclopropyl-6-fluoro-1,4- dihydro-8-methoxy-7-(3-methylaminopiperidin-1-yl)-4-oxoquinoline-3-carboxylic acid |  | C20H24FN3O4 | 詳情 | 供應(yīng)商 |
| 206873-63-4 | Tariquidar; N-[2-[[4-[2-(6,7-二甲氧基-3,4-二氫-1H-異喹啉-2-基)乙基]苯基]氨基甲�；鵠-4,5-二甲氧基苯基] | Tariquidar; N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide |  | C38H38N4O6 | 詳情 | 供應(yīng)商 |
| 262352-17-0 | 托徹普; (2R,4S)-4-[(3,5-雙三氟甲基芐基)甲氧基甲酰氨基]-2-乙基-6-三氟甲基-3,4-二氫-2H-喹啉-1-羧酸乙酯 | Torcetrapib; (2R,4S)-4-[(3,5-Bis-trifluoromethylbenzyl)methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |  | C26H25F9N2O4 | 詳情 | 供應(yīng)商 |
| 380843-75-4 | 伯舒替尼; 博舒替尼; 4-[(2,4-二氯-5-甲氧基苯基)氨基]-6-甲氧基-7-[3-(4-甲基-1-哌嗪)丙氧基]-3-喹啉甲腈 | Bosutinib; 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile |  | C26H29Cl2N5O3 | 詳情 | 供應(yīng)商 |
| 698387-09-6 | (2E)-N-[4-[[3-氯-4-[(吡啶-2-基)甲氧基]苯基]氨基]-3-氰基-7-乙氧基喹啉-6-基]-4-(二甲基氨基)丁-2-烯酰胺 | Neratinib; (2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide |  | C30H29ClN6O3 | 詳情 | 供應(yīng)商 |
| 90-52-8 | 8-氨基-6-甲氧基喹啉; 8-氨基-6-甲氧基喹啉; | 8-Quinolinamine,6-methoxy-; Quinoline,8-amino-6-methoxy- (6CI,7CI); 6-Methoxy-8-aminoquinoline; 6-Methoxyquinolin-8-amine; 6-Methoxyquinolin-8-ylamine; 8-Amino-6-methoxyquinoline; Amichin; NSC 119507; NSC 119508; NSC 13573; WR 15081 |  | C10H10N2O | 詳情 | 供應(yīng)商 |
| 312693-53-1 | 8-氨基-6-甲氧基喹啉氫溴酸鹽 | 8-Quinolinamine,6-methoxy-, hydrobromide (1:1); 8-Quinolinamine,6-methoxy-, monohydrobromide (9CI) |  | C10H11BrN2O | 詳情 | 供應(yīng)商 |
| 151060-21-8 | 巴洛沙星/1-環(huán)丙基-7-(3-甲氨基-1-哌啶基)-8-甲氧基-6-氟-1,4-二氫-4-氧代-3-喹啉羧酸 | Balofloxacin Dihydrate | 無(wú) | C20H28FN3O6 | 詳情 | 供應(yīng)商 |
| 951163-60-3 | 7-[(3S,5S)-3-氨基-5-甲基-1-哌啶基]-1-環(huán)丙基-1,4-二氫-8-甲氧基-4-氧代-3-喹啉甲酸 2-羥基丁二酸 | Butanedioicacid,2-hydroxy-,compd.with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-di; Butanedioicacid,2-hydroxy-,compd.with7-[(3S,5S)-3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylicacid; 7-[(3S,5S)-3-Amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid with 2-hydroxybutanedioic acid |  | C20H25N3O4.C4H6O5 | 詳情 | 供應(yīng)商 |
| 73630-23-6 | QUIN 2; QUIN 2; 2-[(2-氨基-5-甲基苯氧基)甲基]-6-甲氧基-8-氨基喹啉-N,N,N',N'-四乙酸四鉀; 喹啉酸-2 | QUIN 2, TETRAPOTASSIUM SALT; QUIN-2; QUIN 2, TETRAPOTASSIUM SALT; 2-[(2-AMINO-5-METHYLPHENOXY)METHYL]-6-METHOXY-8-AMINO-QUINOLINE-N,N,N',N'-TETRAACETIC ACID TETRAPOTASSIUM SALT; 2-[[2-BIS-(CARBOXYMETHYL)AMINO-5-METHYLPHENOXY]-METHYL]-6-METHOXY-8-BIS-(CARBOXYMETHYL)AMINOQUINOLINE TETRAPOTASSIUM SALT; 2-[[2-BIS(CARBOXYMETHYL)AMINO-5-METHYLPHENOXY]METHYL]-6-METHOXY-8-BIS(CARBOXYMETHYL)AMINOQUINOLINE, 4K; 2-[(2-amino-5-methylphenoxy)methyl]-6-methoxy-8-aminoquinoline-n,n,n',n'-tetraacetic acid tetrapotassium salt; 2-[(2-Amino-5-methylphenoxy)methyl]-6-methoxy-8-aminoquinoline-N,N,Nμ,Nμ-tetraacetic acid tetrapotassium salt, 2-{[2-Bis-(carboxymethyl)amino-5-methylphenoxy]-methyl}-6-methoxy-8-bis-(carboxymethyl)aminoquinoline tetrapotassium salt; N-[2-[[8-[Bis(carboxymethyl)amino]-6-methoxy-2-quinolinyl]methoxy]-4-methylphenyl]-N-(carboxymethyl)glycine tetrapotassium salt |  | C26H23K4N3O10 | 詳情 | 供應(yīng)商 |
| 630420-16-5 | (1R,2S)-N-[(1,1-二甲基乙氧基)羰基]-3-甲基-L-纈氨酰-(4R)-4-[(7-氯-4-甲氧基-1-異喹啉基)氧基]-L-脯氨酰-1-氨基-N-(環(huán)丙基磺�；�)-2-乙烯基環(huán)丙基甲酰胺; (1R,2S)-N-[(1,1-二甲基乙氧基)羰基]-3-甲基-L-纈氨酰-(4R)-4-[(7-氯-4-甲氧基-1-異喹啉基)氧基]-L-脯氨酰-1-氨基-N-(環(huán)丙基磺酰基)-2-乙烯基環(huán)丙基甲酰胺; 阿那匹韋 | (1R,2S)-N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide; (1R,2S)-N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide; Asunaprevir; BMS 650032; Asunaprevir (BMS-650032); BMS 650032/Asunaprevir |  | C35H46ClN5O9S | 詳情 | 供應(yīng)商 |
| 1058137-23-7 | E 3810; 6-[[7-[(1-氨基環(huán)丙基)甲氧基]-6-甲氧基-4-喹啉基]氧基]-N-甲基-1-萘甲酰胺 | E-3810; E-3810; 6-[[7-[(1-Aminocyclopropyl)methoxy]-6-methoxy-4-quinolinyl]oxy]-N-methyl-1-naphthalenecarboxamide | 無(wú) | C26H25N3O4 | 詳情 | 供應(yīng)商 |